SEC Form 4 · accession 0001209191-18-044605
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas A. Edwards
Director
Period of report
Jul 28, 2018
Accepted (ET)
Jul 31, 2018 · 6:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 28, 2018 | M | 6,767 | $0.00 | A | 153,973 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | Jul 28, 2018 | M | 6,767 | D | — | — | Common Stock | 6,767 | 0 | D |
Explanation of responses
- F1Shares were acquired upon vesting of restricted stock units awarded on July 28, 2015.
- F2Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
- F3The restricted stock units vested on July 28, 2018.